Glucagon-Like Peptide-2 (GLP-2) is a hormone produced in the intestines that plays a significant role in regulating various physiological processes, particularly those related to metabolism and ...

Rani Therapeutics (RANI) announced new pharmacokinetic and pharmacodynamic data from a preclinical study evaluating the oral delivery of the ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

Ironwood Pharmaceuticals, Inc.’s IRWD share price has dipped by 10.47%, which has investors questioning if this is right time ...